Further analysis of 31 tumor types with TIMER2.0 indicated that HOXB9 expression was significantly higher in HNSCC, COAD, ESCA, READ, STAD, and UCS, and lower in KIRC and LAML (Fig. 1B). This evidence concerns the gene HOXB9 and head and neck squamous cell carcinoma.